featured
Omecamtiv Mecarbil for Severe Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial
JAMA Cardiol 2021 Oct 13;[EPub Ahead of Print], GM Felker, SD Solomon, B Claggett, R Diaz, JJV McMurray, M Metra, I Anand, MG Crespo-Leiro, U Dahlström, E Goncalvesova, JG Howlett, P MacDonald, A Parkhomenko, J Tomcsányi, SA Abbasi, SB Heitner, T Hucko, S Kupfer, FI Malik, JR TeerlinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.